ES2064958T3 - Gel acuoso a base de acido retinoico y de hidroxipropil-beta-ciclodextrina. - Google Patents

Gel acuoso a base de acido retinoico y de hidroxipropil-beta-ciclodextrina.

Info

Publication number
ES2064958T3
ES2064958T3 ES91403059T ES91403059T ES2064958T3 ES 2064958 T3 ES2064958 T3 ES 2064958T3 ES 91403059 T ES91403059 T ES 91403059T ES 91403059 T ES91403059 T ES 91403059T ES 2064958 T3 ES2064958 T3 ES 2064958T3
Authority
ES
Spain
Prior art keywords
cyclodextrin
beta
retinoic acid
hydroxypropil
aqueous gel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91403059T
Other languages
English (en)
Inventor
Alain Rolland
Braham Shroot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Centre International de Recherches Dermatologiques Galderma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre International de Recherches Dermatologiques Galderma filed Critical Centre International de Recherches Dermatologiques Galderma
Application granted granted Critical
Publication of ES2064958T3 publication Critical patent/ES2064958T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/738—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nanotechnology (AREA)
  • Birds (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Inorganic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

ESTE GEL SE CARACTERIZA POR EL HECHO DE QUE EL ACIDO RETINOICO ESTA PRESENTE, EN ESTADO SOLUBLE Y ESTABLE, EN UNA PROPORCION DE 0,02 A 0,05% EN PESO, EN PRESENCIA DE 6 A 15% EN PESO DE HIDROXIPROPIL-B-CICLODEXTRINA Y DE TRIETANOLAMINA EN UNA PROPORCION TAL QUE EL PH DE DICHO GEL ESTE COMPRENDIDO ENTRE APROXIMADAMENTE 6,8 Y 7,4 Y DE UN AGENTE GELIFICANTE. ESTE GEL ENCUENTRA UNA UTILIZACION EN LOS CAMPOS FARMACEUTICOS Y COSMETICO, EN PARTICULAR EN EL TRATAMIENTO DE DISTINTAS FORMAS DE ACNE, DE LA SORIASIS Y DE OTRAS AFECCIONES DERMATOLOGICAS.
ES91403059T 1990-11-15 1991-11-14 Gel acuoso a base de acido retinoico y de hidroxipropil-beta-ciclodextrina. Expired - Lifetime ES2064958T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU87843A LU87843A1 (fr) 1990-11-15 1990-11-15 Gel aqueux a base d'acide retinoique et d'hydroxypropyl-beta-cyclodextrine et son utilisation en medecine humaine et en cosmetique

Publications (1)

Publication Number Publication Date
ES2064958T3 true ES2064958T3 (es) 1995-02-01

Family

ID=19731263

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91403059T Expired - Lifetime ES2064958T3 (es) 1990-11-15 1991-11-14 Gel acuoso a base de acido retinoico y de hidroxipropil-beta-ciclodextrina.

Country Status (8)

Country Link
EP (1) EP0486395B1 (es)
JP (1) JP2650805B2 (es)
AT (1) ATE113831T1 (es)
CA (1) CA2055578A1 (es)
DE (1) DE69105094T2 (es)
DK (1) DK0486395T3 (es)
ES (1) ES2064958T3 (es)
LU (1) LU87843A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2047456B1 (es) * 1992-07-31 1994-10-01 Herrando Carlos Postigo Composicion para la obtencion de un producto cosmetico y productos similares.
SE9300971D0 (sv) * 1993-03-24 1993-03-24 Jan Wadstein Hudvaardskomposition
ES2083333B1 (es) * 1994-09-22 1997-01-16 Corral Begona Gozalo Crema para el tratamiento de la psoriasis.
CA2281944C (en) * 1997-02-25 2007-05-15 The Regents Of The University Of Michigan Methods and compositions for preventing and treating chronological aging in human skin
ES2190082T3 (es) * 1997-05-02 2003-07-16 Cosmoferm Bv Concentrados estables de vitamina c.
JP2002523475A (ja) * 1998-09-02 2002-07-30 アラーガン・セイルズ・インコーポレイテッド 防腐したシクロデキストリン含有組成物
JP2006510652A (ja) * 2002-12-12 2006-03-30 ガルデルマ・リサーチ・アンド・デヴェロップメント・エス・エヌ・セ フェノール誘導体およびレチノイド含有水−アルコール脱色ゲル
JP4781680B2 (ja) * 2005-01-17 2011-09-28 株式会社Ａｄｅｋａ 防腐剤組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4371673A (en) * 1980-07-21 1983-02-01 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble forms of retinoids
DE3346123A1 (de) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
GB8910069D0 (en) * 1989-05-03 1989-06-21 Janssen Pharmaceutica Nv Method of topically treating acne vulgaris
FR2647015B1 (fr) * 1989-05-17 1994-05-06 Cird Gel aqueux a base d'acide retinoique et son utilisation en medecine humaine et en cosmetique

Also Published As

Publication number Publication date
DE69105094T2 (de) 1995-05-18
EP0486395A1 (fr) 1992-05-20
JPH0656622A (ja) 1994-03-01
JP2650805B2 (ja) 1997-09-10
DE69105094D1 (de) 1994-12-15
DK0486395T3 (da) 1995-04-24
EP0486395B1 (fr) 1994-11-09
CA2055578A1 (fr) 1992-05-16
ATE113831T1 (de) 1994-11-15
LU87843A1 (fr) 1992-08-25

Similar Documents

Publication Publication Date Title
DE69733687D1 (de) Kosmetische zusammensetzung fuer hautregenerierung ohne hautreizung
EP0068552A3 (en) Topical antimicrobial composition
MY105521A (en) Moisturizing vehicle for topical application of vitamin a acid.
DE68917512D1 (de) Kosmetisches Präparat.
ES2130307T3 (es) Preparados cosmeticos y dermatologicos con un contenido en acido delta-aminolevulinico.
NO302274B1 (no) Anvendelse av 9-cis retinsyre
FR2768927B1 (fr) Utilisation de l'acide ellagique, de ses sels, de ses complexes metalliques, de ses derives mono- ou poly-ethers, mono- ou poly-acyles dans le domaine de la cosmetique et de la pharmacie, notamment de la dermatologie
RU93005355A (ru) Фармакологические композиции
DE68910377D1 (de) Kosmetisches Präparat.
ATE161419T1 (de) Kosmetische zusammensetzung, die einen lipidstoff und eine hydroxy - oder ketofettsäure enthält
ES2064958T3 (es) Gel acuoso a base de acido retinoico y de hidroxipropil-beta-ciclodextrina.
DE69419981D1 (de) Retinoid enthaltendes Mittel
ATE221780T1 (de) Fenbendazolformulierungen
NO173705C (no) Kosmetisk preparat for topisk paafoering
FR2416009A1 (fr) Substance cosmetique active a base de proteines de la peau
FI910112A (fi) Preparat foer lokalt bruk.
NO902104L (no) Kosmetisk blanding.
ITMI912466A1 (it) Uso di 1, 2 dipalmitoil-l-alfa-fosfatidil-n, n-dimetiletanolammina, in composizioni dermatologiche
ES2106689A1 (es) Nueva formulacion a base de acido hidroxicitrico (sales y derivados) y sus aplicaciones cosmeticas y farmaceuticas por via topica percutanea.
CO4600670A1 (es) Composiciones topicas acuosas que comprenden un agente anti- acne acido y un glicoleter soluble en agua

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 486395

Country of ref document: ES